Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05303532
Title Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab (ROSY-D)
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca

hematologic cancer

Advanced Solid Tumor



Age Groups: senior | adult
Covered Countries ITA | FRA | DEU | CAN

No variant requirements are available.